Adagene inc.

Major-Pharmaceuticals

ADAG


Executive/
Director

Price

  • Last Close
  • $ 2.02
    $ -0.04 -1.94 %
    Jan 3, 2025
  • 52-Week High/Low
  • $4.15 - $1.25
  • YTD
  • 1.5%

  • Trading Volume
  • 553
  • Market Cap Full
  • $ 109.2M
  • Shares Outstanding
  • 54.1M
    Dec 31, 2022
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - - - - -56.7% 6.8% 46.4% 1.5%
Q2 - - - - - -24.5% -41% 0.7% -18.5% -
Q3 - - - - - 5.9% -38% 1.4% 19.2% -
Q4 - - - - - -43.8% 3.1% 34.3% -10.4% -
J F M A M J J A S O N D
2025 1.5% - - - - - - - - - - -
2024 90.6% -13.4% -11.4% -6.1% - - - 19.2% - - - 80.9%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%0%0%0%-84%45%4%2%

Earnings

2018 2019 2020 2021 2022 2023
Q1 - - - - - -
Q2 - - - - - -
Q3 - - - - - -
Q4 - - - - - -
A -0.9 -1.1 -2.7 -1.5 -1.5 0

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2020 2021 2022
Mar - - -
Jun - - -
Sep - - -
Dec 43.9 54.6 54.1

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 3 3.3 0.2 - -
Total Asset Turnover 0.1 0.1 - - -
Leverage
Debt Ratio 0.1 - - - -
Debt – Equity Ratio 0.2 - - - -
Interest Coverage 21 -72 43 6.3 -
Equity multiplier - - -0.1 - -